EDNRA and nasopharyngeal carcinoma: ABT-627, an antagonist of ETAR, can significantly inhibit the growth of NPC xenografts in nude mice, reduce metastatic lesions in the lung, and enhance the sensitivity of the tumors to chemotherapy [9].